Live Science on MSNOpinion
From gene therapy breakthroughs to preventable disease outbreaks: The health trends that will shape 2026
Live Science's health channel editor makes predictions about the medical breakthroughs and public health shifts to come in ...
Matthew Herper covers medical innovation — both its promise and its perils. It has been a tough year for medicine. The U.S.
Zacks Investment Research on MSN
Can BEAM's gene editing pipeline create long-term value amid rivalry?
Beam Therapeutics BEAM is engaged in developing investigational gene therapy candidates that are currently in ...
Now, Musunuru and colleagues are preparing a master clinical protocol to study a CRISPR therapy that's mostly the same as the one they used to treat baby KJ, except they plan to swap out the gene ...
A small group of volunteers will receive multiple injections of the experimental treatments next month, says Unlimited Bio.
CORONA, Calif. (KABC) -- A teenage girl is alive thanks to an experimental gene therapy treatment created at UCLA. She was born with a rare genetic disorder, so any common infection could've killed ...
A California toddler is the first person in the world to receive gene therapy to treat his devastating disease. Three-year-old Oliver Chu was born with a rare, genetic condition called Hunter syndrome ...
Mixed headlines have plagued the cell and gene therapy space of late. We believe that a renewed case of optimism is not only warranted but essential if these therapies are to reach their full ...
In a highly anticipated article, FDA officials Vinay Prasad, M.D., and Martin Makary, M.D., outlined a novel regulatory pathway that could trigger a seismic shift in how bespoke gene editing therapies ...
A blood stem cell gene therapy co-developed by UCLA’s Dr. Donald Kohn restored immune function in 59 of 62 children with ADA-SCID, a rare and fatal immune disorder, with no serious complications ...
An experimental gene therapy developed by researchers at UCLA, University College London and Great Ormond Street Hospital has restored and maintained immune system function in 59 of 62 children born ...
An experimental gene therapy was found to slow the progression of Huntington’s disease in a “pivotal” Phase 1/2 study, according to drugmaker uniQure, marking a major step toward a potential first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results